Richard R. Deluca
EVP&Pres, Merck Animal Heallth · Merck & Co., Inc.
- 2026
- Aug 12, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard R. Deluca files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Zachary - $25.20M in MRK purchases and sales in the last 12 months
- Chirfi Guindo - $8.15M in MRK purchases and sales in the last 12 months
- David Michael Williams - $8.13M in MRK purchases and sales in the last 12 months
- Robert M. Davis - $5.60M in MRK purchases and sales in the last 12 months
- Caroline Litchfield - $5.02M in MRK purchases and sales in the last 12 months
- Dean Y. Li - $2.99M in MRK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard R. Deluca?
Richard R. Deluca is a corporate insider, tracked as EVP&Pres, Merck Animal Heallth of Merck & Co., Inc. (MRK). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard R. Deluca submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Richard R. Deluca been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($11.29M) across all tracked filings.
